Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | serine:threonine protein kinase 3 | 0.0456 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0406 | 0.8868 | 0.8868 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0107 | 0.2053 | 1 |
Trypanosoma cruzi | STE/STE20 serine/threonine-protein kinase, putative | 0.0107 | 0.2053 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0209 | 0.4374 | 1 |
Entamoeba histolytica | serine/threonine protein kinase STE20, putative | 0.0107 | 0.2053 | 0.4692 |
Echinococcus granulosus | leucine rich repeat serine:threonine protein | 0.0409 | 0.893 | 0.893 |
Plasmodium vivax | serine/threonine-specific protein kinase, putative | 0.0209 | 0.4374 | 1 |
Echinococcus multilocularis | leucine rich repeat serine:threonine protein | 0.0406 | 0.8868 | 0.8868 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0209 | 0.4374 | 0.4374 |
Echinococcus granulosus | serine:threonine protein kinase 3 | 0.0456 | 1 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0209 | 0.4374 | 1 |
Plasmodium falciparum | protein kinase, putative | 0.0209 | 0.4374 | 1 |
Trichomonas vaginalis | STE family protein kinase | 0.0209 | 0.4374 | 1 |
Loa Loa (eye worm) | STE/STE20/YSK protein kinase | 0.0209 | 0.4374 | 0.4374 |
Echinococcus multilocularis | myosin iiia | 0.0107 | 0.2053 | 0.2053 |
Trichomonas vaginalis | STE family protein kinase | 0.0107 | 0.2053 | 0.4692 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0209 | 0.4374 | 0.5745 |
Echinococcus granulosus | serine threonine protein kinase | 0.0209 | 0.4374 | 0.4374 |
Onchocerca volvulus | 0.0017 | 0 | 0.5 | |
Trypanosoma brucei | STE20-like serine/threonine-protein kinase 1, putative | 0.0107 | 0.2053 | 1 |
Loa Loa (eye worm) | STE/STE20/MST protein kinase | 0.0456 | 1 | 1 |
Leishmania major | protein kinase, putative | 0.0107 | 0.2053 | 1 |
Onchocerca volvulus | Mitochondrial Rho GTPase homolog | 0.0017 | 0 | 0.5 |
Schistosoma mansoni | ste20-related kinase | 0.0351 | 0.7614 | 1 |
Entamoeba histolytica | serine/threonine-protein kinase 3, putative | 0.0107 | 0.2053 | 0.4692 |
Loa Loa (eye worm) | TKL/LRRK protein kinase | 0.0406 | 0.8868 | 0.8868 |
Giardia lamblia | Kinase, STE STE20 | 0.0107 | 0.2053 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.585 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.